文献速递前列腺癌

英国前列腺癌男性生存质量的区域差异

Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.
PubMed 文献 · Eur Urol · 2019-05-04

该研究对英国35823名前列腺癌幸存者(应答率60.8%)进行横断面邮寄调查,使用EPIC-26问卷评估泌尿、肠道、性功能及活力问题。多变量对数线性回归显示,尽管调整了治疗及临床社会人口学因素,生存质量仍因居住地区而异,威尔士、苏格兰、北爱尔兰及英格兰部分区域表现较差。作者认为可借鉴表现良好区域的最佳实践以改善薄弱区域的生存质量。

要点

  • 威尔士和苏格兰自评健康显著低于英国平均水平。
  • 苏格兰报告更多尿失禁,苏格兰和北爱尔兰报告更多肠道问题。
  • 英格兰南约克郡及东北与坎布里亚自评健康差于英格兰平均水平。

核心结论

  • 尽管调整了治疗及临床社会人口学因素,前列腺癌幸存者的生存质量仍因居住地区而异。
  • 作者认为借鉴表现良好区域的最佳实践可支持改善表现较差区域的生存质量,尤其在肠道问题和活力方面存在临床相关差异。

研究设计与样本

  • 横断面邮寄调查,纳入既往18-42个月内诊断的前列腺癌幸存者。
  • 共35823名男性应答,占受邀者的60.8%。
  • 使用EPIC-26问卷患者报告泌尿、肠道、性问题及活力,并自评总体健康。
  • 采用多变量对数线性回归识别区域差异。

主要发现

  • 威尔士和苏格兰的自评健康显著低于英国平均水平。
  • 苏格兰报告更多尿失禁;苏格兰和北爱尔兰报告更多泌尿刺激/梗阻症状。
  • 苏格兰和北爱尔兰肠道功能更差;苏格兰性功能更差。
  • 苏格兰、威尔士和北爱尔兰活力/激素功能降低。
  • 英格兰南约克郡及东北与坎布里亚自评健康差于英格兰平均水平;东北与坎布里亚及Peninsula尿失禁更多;西米德兰兹性问题更多;东北与坎布里亚及西米德兰兹活力更差。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 难以识别临床显著差异。
  • 关于治疗前状况的信息有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prostate cancer incidence, treatment, and survival rates vary throughout the UK, but little is known about regional differences in quality of survival. OBJECTIVE: To investigate variations in patient-reported outcomes between UK countries and English Cancer Alliances. DESIGN, SETTING, AND PARTICIPANTS: A cross-sectional postal survey of prostate cancer survivors diagnosed 18-42mo previously. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Urinary, bowel, and sexual problems and vitality were patient reported using the Expanded Prostate Cancer Index Composite (EPIC-26) questionnaire. General health was also self-assessed. Regional variations were identified using multivariable log-linear regression. RESULTS AND LIMITATIONS: A total of 35823 men responded, 60.8% of those invited. Self-assessed health was significantly lower than the UK average in Wales and Scotland. Respondents reported more urinary incontinence in Scotland, more urinary irritation/obstruction in Scotland and Northern Ireland (NI), poorer bowel function in Scotland and NI, worse sexual function in Scotland, and reduced vitality/hormonal function in Scotland, Wales, and NI. Self-assessed health was poorer than the English average in South Yorkshire and North-East and Cumbria, with more urinary incontinence in North-East and Cumbria and Peninsula, greater sexual problems in West Midlands, and poorer vitality in North-East and Cumbria and West Midlands. Limitations include difficulty identifying clinically significant differences and limited information on pretreatment conditions. CONCLUSIONS: Despite adjustment for treatment, and clinical and sociodemographic factors, quality of survival among prostate cancer survivors varied by area of residence. Adoption of best practice from areas performing well could support enhanced survival quality in poorer performing areas, particularly with regard to bowel problems and vitality, where clinically relevant differences were reported. PATIENT SUMMARY: We conducted a UK-wide survey of patient's quality of life after treatment for prostate cancer. Outcomes were found to vary depending upon where patients live. Different service providers need to ensure that all prostate cancer patients receive the same follow-up care.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Donnelly DW, Gavin A, Downing A, et al. Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom. Eur Urol. 2019. PMID: 31060822. doi:10.1016/j.eururo.2019.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。